Reducing Immunogenicity of Pegloticase With Concomitant Use of Mycophenolate Mofetil in Patients With Refractory Gout: A Phase II, Randomized, Double‐Blind, Placebo‐Controlled Trial

2020 American College of Rheumatology Guideline for the Management of Gout

(2020) John D. FitzGerald et al.   ARTHRITIS CARE & RESEARCH

Increased Efficacy and Tolerability of Pegloticase in Patients With Uncontrolled Gout Co-Treated With Methotrexate: A Retrospective Study

(2020) John A. Albert et al.   Rheumatology and Therapy

Pretreatment and Coadministration With Methotrexate Improved Durability of Pegloticase Response

(2020) John K. Botson et al.   JCR-JOURNAL OF CLINICAL RHEUMATOLOGY

Recapture and improved outcome of pegloticase response with methotrexate–A report of two cases and review of the literature

(2018) Sarah Y. Bessen et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

Pegloticase failure and a possible solution: Immunosuppression to prevent intolerance and inefficacy in patients with gout

(2017) Adey A. Berhanu et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

Validity of PROMIS physical function measured in diverse clinical samples

(2016) Benjamin D. Schalet et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Patients with Gout Treated with Conventional Urate-lowering Therapy: Association with Disease Control, Health-related Quality of Life, and Work Productivity

(2016) R. Wood et al.   JOURNAL OF RHEUMATOLOGY

Performance of Gout Impact Scale in a longitudinal observational study of patients with gout

(2016) Beth Wallace et al.   RHEUMATOLOGY

New advances in the treatment of gout: review of pegloticase

(2016) Mark Reinders   Therapeutics and Clinical Risk Management

Relative efficacy and safety of tacrolimus, mycophenolate mofetil, and cyclophosphamide as induction therapy for lupus nephritis: a Bayesian network meta-analysis of randomized controlled trials

(2015) Y H Lee et al.   LUPUS

A world of hurt: failure to achieve treatment goals in patients with gout requires a paradigm shift

(2015) Puja Khanna et al.   POSTGRADUATE MEDICINE

2015 Gout Classification Criteria: An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative

(2015) Tuhina Neogi et al.   Arthritis & Rheumatology

Infusion-Related Reactions With Pegloticase, a Recombinant Uricase for the Treatment of Chronic Gout Refractory to Conventional Therapy

(2015) Herbert S. B. Baraf et al.   JCR-JOURNAL OF CLINICAL RHEUMATOLOGY

Induced and pre-existing anti-polyethylene glycol antibody in a trial of every 3-week dosing of pegloticase for refractory gout, including in organ transplant recipients

(2014) Michael S Hershfield et al.   ARTHRITIS RESEARCH & THERAPY

Pegloticase immunogenicity: the relationship between efficacy and antibody development in patients treated for refractory chronic gout

(2014) Peter E Lipsky et al.   ARTHRITIS RESEARCH & THERAPY

2012 American College of Rheumatology guidelines for management of gout. Part 2: Therapy and antiinflammatory prophylaxis of acute gouty arthritis

(2012) Dinesh Khanna et al.   ARTHRITIS CARE & RESEARCH

An Evidence-Based Systematic Review on Medical Therapies for Inflammatory Bowel Disease

(2011) Nicholas J Talley et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Prevalence of Contraindications and Prescription of Pharmacologic Therapies for Gout

(2011) Robert T. Keenan et al.   AMERICAN JOURNAL OF MEDICINE

Efficacy and Tolerability of Pegloticase for the Treatment of Chronic Gout in Patients Refractory to Conventional Treatment

(2011)   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Efficacy and safety of enteric-coated mycophenolate sodium in combination with two glucocorticoid regimens for the treatment of active lupus nephritis

(2011) M Zeher et al.   LUPUS

Frequency and risk factors of gout flares in a large population-based cohort of incident gout

(2011) D. Rothenbacher et al.   RHEUMATOLOGY

High versus low dosing of oral colchicine for early acute gout flare: Twenty-four-hour outcome of the first multicenter, randomized, double-blind, placebo-controlled, parallel-group, dose-comparison colchicine study

(2010) Robert A. Terkeltaub et al.   ARTHRITIS AND RHEUMATISM

The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management

(2010) A. Dignass et al.   Journal of Crohns & Colitis

Predictors of doctor-rated and patient-rated gout severity: gout impact scales improve assessment

(2010) Andrew J. Sarkin et al.   JOURNAL OF EVALUATION IN CLINICAL PRACTICE

Efficacy and Adverse Events of Mycophenolate Mofetil Versus Cyclophosphamide for Induction Therapy of Lupus Nephritis

(2010) Nanticha Kamanamool et al.   MEDICINE

Reduction of plasma urate levels following treatment with multiple doses of pegloticase (polyethylene glycol-conjugated uricase) in patients with treatment-failure gout: Results of a phase II randomized study

(2008) John S. Sundy et al.   ARTHRITIS AND RHEUMATISM